Vitiligo Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Growth Factors of VitiligTreatment Market
The vitiligtreatment market size was valued at USD 1243.8 million in 2018, and the market is now projected tgrow USD 2764.3 million in 2032 exhibiting a CAGR of 5.9% during the forecast period of 2019-2032.
COVID 19 influence the vitiligtreatment market ta greater extent as several healthcare facilities are focused on the management of the virus and in turn, the diagnosis and treatment of vitiligand many other diseases were postponed. Others led tdisruptions of in-person consultations, thus delays in the commencement of treatment processes. Nevertheless, in the absence of lockdown, those clients seeking treat for their mental issues or skin conditions such as vitilighad acquired greater increase in awareness and hence increased uptake post lockdown. Telemedicine saved the ability tcontinue receiving consultations and obtain prescriptions for topical agents. It is anticipated that the market will bounce back and grow since the various healthcare systems are adopted tthe newer ways of treatment delivery, as well as; there an increased demand for effective prevention and treatment technologies.
The worldwide vitiligtreatment market is expanding because of a large population of patients and a greater focus on the disease in recent years that has led tthe demand for better treatment. As it stands now, there is nknown treatment for vitiligo, thus the need for more gains in the developed and developing worlds. The American Academy of Dermatology (AAD) estimates that the disease affects about 84.5 million people or one in four, in the United States. The high prevalence of this situation is ensuring the desire for new treatments. Because of increasing awareness on the disease, there is the pressure for such scientists tcome up with new inventions as well as research for possible treatment tthe disease, which is vitiligo.
The current emerging trends identified in the Vitiligtreatment market include rising research on biologics like JAK inhibitors that has shown a potential for regimentation. It is alsobserved that treatments are being individualized by focusing on patents’ characteristics and genetic data. There are topical corticosteroids and calcineurin inhibitors but the methods of phototherapy are in a process of development. Also, the progress in combination therapy with topical agents and lasers has enhanced the general effectiveness of treatment. For gene therapy and stem cell research there is hope for more effective and permanent cure tvitiligsoon.
Comprehensive Analysis of VitiligTreatment Market
The vitiligtreatment market growth is rising at an exponential rate due tits market segmentation. This market expansion rightly provides a thorough market breakdown near tthe industry considering the leading supply and demand forces. These segmentations are methodically segregated by treatment, by disease type, by end user and by geography. By treatment includes topical treatment, light therapy, surgical procedures, and others. By disease type includes nonsegmental vitiligo, and segmental vitiligo. By end user type includes hospitals, aesthetic clinics, and others. By geography includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The North America region lead the vitiligtreatment market share by benefitting a market size of USD 7030.3 million in 2018 due tincreased diagnosis of lung cancer.
The top players in the markets have a central responsibility in the healthcare industry tbe sure of industrial prospectus development and testablish the market norms. These players include, Incyte Corporation, Astellas Pharma Inc., Bausch Health Companies Inc., Baxter International Inc., Pfizer Inc., STRATA Skin Sciences, and Reddy’s Laboratories Ltd these market players provide a level-playing competitive landscape.
In June 2019, Incyte reported positive results from a Phase 2 study of ruxolitinib cream in patients with vitiligo.
Segmentation Table
SEGMENTATION DETAILS
By Treatment
Topical Treatment
Light Therapy
Surgical Procedures
Others
By Disease Type
Nonsegmental Vitiligo
Segmental Vitiligo
By End User
Hospitals
Aesthetic Clinics
Others
By Geography
North America (the USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexicand Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
The vitiligtreatment market size was valued at USD 1243.8 million in 2018, and the market is now projected tgrow USD 2764.3 million in 2032 exhibiting a CAGR of 5.9% during the forecast period of 2019-2032.
COVID 19 influence the vitiligtreatment market ta greater extent as several healthcare facilities are focused on the management of the virus and in turn, the diagnosis and treatment of vitiligand many other diseases were postponed. Others led tdisruptions of in-person consultations, thus delays in the commencement of treatment processes. Nevertheless, in the absence of lockdown, those clients seeking treat for their mental issues or skin conditions such as vitilighad acquired greater increase in awareness and hence increased uptake post lockdown. Telemedicine saved the ability tcontinue receiving consultations and obtain prescriptions for topical agents. It is anticipated that the market will bounce back and grow since the various healthcare systems are adopted tthe newer ways of treatment delivery, as well as; there an increased demand for effective prevention and treatment technologies.
The worldwide vitiligtreatment market is expanding because of a large population of patients and a greater focus on the disease in recent years that has led tthe demand for better treatment. As it stands now, there is nknown treatment for vitiligo, thus the need for more gains in the developed and developing worlds. The American Academy of Dermatology (AAD) estimates that the disease affects about 84.5 million people or one in four, in the United States. The high prevalence of this situation is ensuring the desire for new treatments. Because of increasing awareness on the disease, there is the pressure for such scientists tcome up with new inventions as well as research for possible treatment tthe disease, which is vitiligo.
The current emerging trends identified in the Vitiligtreatment market include rising research on biologics like JAK inhibitors that has shown a potential for regimentation. It is alsobserved that treatments are being individualized by focusing on patents’ characteristics and genetic data. There are topical corticosteroids and calcineurin inhibitors but the methods of phototherapy are in a process of development. Also, the progress in combination therapy with topical agents and lasers has enhanced the general effectiveness of treatment. For gene therapy and stem cell research there is hope for more effective and permanent cure tvitiligsoon.
Comprehensive Analysis of VitiligTreatment Market
The vitiligtreatment market growth is rising at an exponential rate due tits market segmentation. This market expansion rightly provides a thorough market breakdown near tthe industry considering the leading supply and demand forces. These segmentations are methodically segregated by treatment, by disease type, by end user and by geography. By treatment includes topical treatment, light therapy, surgical procedures, and others. By disease type includes nonsegmental vitiligo, and segmental vitiligo. By end user type includes hospitals, aesthetic clinics, and others. By geography includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The North America region lead the vitiligtreatment market share by benefitting a market size of USD 7030.3 million in 2018 due tincreased diagnosis of lung cancer.
The top players in the markets have a central responsibility in the healthcare industry tbe sure of industrial prospectus development and testablish the market norms. These players include, Incyte Corporation, Astellas Pharma Inc., Bausch Health Companies Inc., Baxter International Inc., Pfizer Inc., STRATA Skin Sciences, and Reddy’s Laboratories Ltd these market players provide a level-playing competitive landscape.
In June 2019, Incyte reported positive results from a Phase 2 study of ruxolitinib cream in patients with vitiligo.
Segmentation Table
SEGMENTATION DETAILS
By Treatment
Topical Treatment
Light Therapy
Surgical Procedures
Others
By Disease Type
Nonsegmental Vitiligo
Segmental Vitiligo
By End User
Hospitals
Aesthetic Clinics
Others
By Geography
North America (the USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexicand Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Table of Contents
138 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of vitiligo by key countries
- 4.2. Pipeline analysis
- 4.3. Recent industry developments - mergers & acquisitions
- 4.4. Recent developments in R&D
- 5. Global Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Treatment
- 5.2.1. Topical Treatment
- 5.2.2. Light Therapy
- 5.2.3. Surgical Procedures
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Disease Type
- 5.3.1. Nonsegmental Vitiligo
- 5.3.2. Segmental Vitiligo
- 5.4. Market Analysis, Insights and Forecast – By End-user
- 5.4.1. Hospitals
- 5.4.2. Aesthetic Clinics
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Treatment
- 6.2.1. Topical Treatment
- 6.2.2. Light Therapy
- 6.2.3. Surgical Procedures
- 6.2.4. Others
- 6.3. Market Analysis – By Disease Type
- 6.3.1. Nonsegmental Vitiligo
- 6.3.2. Segmental Vitiligo
- 6.4. Market Analysis – By End-user
- 6.4.1. Hospitals
- 6.4.2. Aesthetic Clinics
- 6.4.3. Others
- 6.5. Market Analysis – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Treatment
- 7.2.1. Topical Treatment
- 7.2.2. Light Therapy
- 7.2.3. Surgical Procedures
- 7.2.4. Others
- 7.3. Market Analysis – By Disease Type
- 7.3.1. Nonsegmental Vitiligo
- 7.3.2. Segmental Vitiligo
- 7.4. Market Analysis – By End-user
- 7.4.1. Hospitals
- 7.4.2. Aesthetic Clinics
- 7.4.3. Others
- 7.5. Market Analysis – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia pacific Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Treatment
- 8.2.1. Topical Treatment
- 8.2.2. Light Therapy
- 8.2.3. Surgical Procedures
- 8.2.4. Others
- 8.3. Market Analysis – By Disease Type
- 8.3.1. Nonsegmental Vitiligo
- 8.3.2. Segmental Vitiligo
- 8.4. Market Analysis – By End-user
- 8.4.1. Hospitals
- 8.4.2. Aesthetic Clinics
- 8.4.3. Others
- 8.5. Market Analysis – By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Treatment
- 9.2.1. Topical Treatment
- 9.2.2. Light Therapy
- 9.2.3. Surgical Procedures
- 9.2.4. Others
- 9.3. Market Analysis – By Disease Type
- 9.3.1. Nonsegmental Vitiligo
- 9.3.2. Segmental Vitiligo
- 9.4. Market Analysis – By End-user
- 9.4.1. Hospitals
- 9.4.2. Aesthetic Clinics
- 9.4.3. Others
- 9.5. Market Analysis – By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Treatment
- 10.2.1. Topical Treatment
- 10.2.2. Light Therapy
- 10.2.3. Surgical Procedures
- 10.2.4. Others
- 10.3. Market Analysis – By Disease Type
- 10.3.1. Nonsegmental Vitiligo
- 10.3.2. Segmental Vitiligo
- 10.4. Market Analysis – By End-user
- 10.4.1. Hospitals
- 10.4.2. Aesthetic Clinics
- 10.4.3. Others
- 10.5. Market Analysis – By Country/Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.5.1. Incyte Corporation
- 11.5.2. Astellas Pharma Inc.
- 11.5.3. Bausch Health Companies Inc.
- 11.5.4. Baxter International Inc.
- 11.5.5. Dr. Reddy’s Laboratories Ltd.
- 11.5.6. Pfizer Inc.
- 11.5.7. STRATA Skin Sciences
- 12. Strategic Recommendation "
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
